Regencell Bioscience Holdings Limited recorded a cumulative net loss of $-4 million during 12 month ending in the fourth quarter 2025.
The Consumer Non Cyclical sector has seen employees of 9 other companies achieving higher income per employee. While Regencell Bioscience Holdings Limited's total ranking has deteriorated compared to the previous quarter from to 3023.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

RGC Net Income per Employee	(Jun 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Jun 30 2023) IV. Quarter
Y / Y Net Income Change	-	-	-	-	-
Net Income per Employee (TTM) $	-325,838	-551,121	-551,121	-551,121	-551,121
RGC's Total Ranking	# 3023	#	#	#	#
Seq. Net Income Change	-	-	-	-	-

RGC Company Profile >> Back to RGC Efficiency Comparisons >> Compare RGC Net Income per Employee to its Competitors

RGC Net Income per Employee Company Ranking
Within:	No.
Legal Cannabis Industry	# 10
Consumer Non Cyclical Sector	# 127
Overall Market	# 3023

Net Income per Employee Statistics
High	Average	Low
$ 16,200,000	$ 10,186,661	$ -690,414
(Mar 31 2017)		(Jun 30 2022)

Companies with similar Income per Employee for 12 month ending Jun 30 2025, within Consumer Non Cyclical Sector

Income per Employee

Income 12 month ending Jun 30 2025

Number of Employees Jun 30 2025

Date modified: 2025-11-01T05:56:14+00:00

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.